Showing results (61-70 of 69) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Therapeutic Drug Monitoring|November 16, 2020
Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic DrugsGeorgios Schoretsanitis, Pierre Baumann, Andreas Conca, et al.The Journal of Clinical Psychiatry|July 20, 2023
Therapeutic Reference Range for Olanzapine in Schizophrenia: Systematic Review on Blood Concentrations, Clinical Effects, and Dopamine Receptor OccupancyKatja Wesner, Christoph Hiemke, Niels Bergemann, et al.Pharmacology|June 16, 2007
Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory testsGerald Zernig, Serge H Ahmed, Rudolf N Cardinal, et al.Frontiers in Psychiatry|November 3, 2022
Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancyLuzie Eichentopf, Christoph Hiemke, Andreas Conca, et al.The Journal of Clinical Psychiatry|May 21, 2020
Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und PharmakopsychiatrieGeorgios Schoretsanitis, John M Kane, Christoph U Correll, et al.The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 24, 2024
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychoticsXenia Marlene Hart, Gerhard Gründer, Nicolas Ansermot, et al.The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 2, 2018
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for cliniciansGeorgios Schoretsanitis, Michael Paulzen, Stefan Unterecker, et al.Der Nervenarzt|November 18, 2018
[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.Pharmacopsychiatry|July 2, 2026
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspectsXenia M Hart, Gerhard Gründer, Christoph Hiemke, et al.Pageof 7